We found that in our treated group, over 75 percent of the cancer cells we initially injected were dead or dying, in comparison to only around 25 percent.
Descobrimos que no nosso grupo experimental, mais de 75% das células que injetámos estavam mortas ou a morrer, contra os apenas 25% anteriores.